Medical Aesthetics Market by Products, Procedures, & End-Users - Global Forecast to 2020

The global medical aesthetics market is estimated to grow at a CAGR of 10.8% from 2015 to 2020. North America held the largest share of the medical aesthetics market in 2015. However, the Asia-Pacific region is poised to grow at the highest CAGR of 12.6% in the next five years. Factors such as rising consumer awareness and interest in aesthetic procedures, strong local economies, aggressive marketing by leading U.S. and European companies in Asia, decreasing social taboos, and rising medical tourism are propelling its growth.

The growth of the global medical aesthetics market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, aging population, increasing awareness among customers, technological advancements in energy-based devices, rising number of aesthetic procedures, and increasing demand for aesthetic treatments among the male population. However, a stringent safety regulation for aesthetic procedures is a major factor restraining the growth of this market. Growing adoption of home use aesthetic devices and increasing demand for cosmetic treatments in emerging markets are creating opportunities for growth of the medical aesthetics market.

In this report, the global medical aesthetics market has been classified into many segments and subsegments on the basis of products, namely, aesthetic lasers and energy devices, aesthetic implants, and facial aesthetics. The aesthetic lasers and energy devices segment is categorized into laser resurfacing devices, body contouring devices, laser hair removal, and aesthetic ophthalmology devices. Laser resurfacing devices segment is further divided into ablative skin resurfacing devices, and non-ablative skin resurfacing devices. Body contouring devices segment is classified into liposuction devices (laser assisted liposuction devices, ultrasound assisted liposuction devices, radiofrequency assisted liposuction devices, water jet assisted liposuction devices, and other liposuction devices), cellulite reduction devices (energy based cellulite reduction devices, lipomassage devices, and mesotherapy devices), non-surgical fat reduction devices (cryolipolysis devices, laser based devices, radio frequency based devices, and ultrasound based devices), and non-surgical skin tightening devices (laser based devices, radio frequency based devices, and ultrasound based devices).

The aesthetic implants segment is classified into breast implants (silicone breast implants, saline breast implants, and cohesive semi-solid gel implants), and other implants (aesthetic dental implants, and soft tissue implants). The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peel, microdermabrasion, and dermal fillers (absorbable dermal fillers, and non-absorbable dermal fillers).

The aesthetic lasers and energy devices segment accounted for the largest share of the global medical aesthetics market in 2015, followed by the facial aesthetics segment. Factors such as the increasing number of aesthetic procedures, high prevalence of overweight and obesity, technological advancements, and rising adoption of minimally invasive and non-invasive cosmetic procedures are stimulating the growth of the aesthetic lasers and energy devices market.

Geographically, North America (comprising the U.S. and Canada) commanded the largest share of 49.0% of the global medical aesthetics market in 2015, followed by Europe. North America will continue to lead in the years to come, owing to rapidly aging and obese population, technological advancements, and growing FDA approvals of devices in the U.S.

Currently, the medical aesthetics market is a diversified and competitive market with a large number of players. In 2014, Cynosure Inc., Syneron Medical Ltd., Solta Medical, Inc., ZELTIQ Aesthetics, Inc., Lumenis Ltd., and PhotoMedex, Inc. were the leading companies in the global medical aesthetics laser and energy devices market. Moreover, in 2014, Allergan, Inc., Galderma S.A., and Merz Aesthetics, Inc. were the leading players in the global facial aesthetics market. The breast implants market was dominated by Allergan, Inc. and Mentor Corporation in 2014. New product launches; agreements, partnerships, and alliances; mergers, acquisitions, and joint ventures; awareness and marketing campaigns, and new facility launches are the major strategies adopted by most of the market players to achieve growth in the medical aesthetics market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis —industry analysis, market share analysis of various segments and sub-segments, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the medical aesthetics market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned four strategies (market penetration, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on medical aesthetic devices offered by the top 10 players in the medical aesthetics market. The report analyzes the medical aesthetics market on the basis of product, procedure, end user, and region

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various medical aesthetics across geographies

‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the medical aesthetics market

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the medical aesthetics market

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Breakdown of primary interviews 25
2.1.2.2 Key data from primary sources 26
2.1.2.3 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 27
2.2.1.1 Bottom-up approach 27
2.2.1.2 Top-down approach 28
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 30
2.4.1 ASSUMPTIONS 30
2.4.2 LIMITATIONS 30
3 EXECUTIVE SUMMARY 31
3.1 INTRODUCTION 31
3.2 CURRENT SCENARIO 32
3.3 FUTURE OUTLOOK 34
3.4 CONCLUSION 36
4 PREMIUM INSIGHTS 37
4.1 ATTRACTIVE OPPORTUNITIES IN THE MEDICAL AESTHETICS MARKET 37
4.2 MEDICAL AESTHETICS MARKET GROWTH RATE, BY PRODUCT AND REGION
(2015–2020) 38
4.3 MEDICAL AESTHETICS MARKET, BY PRODUCT AND REGION, 2015 & 2020 ($MILLION) 39
4.4 MEDICAL AESTHETICS MARKET, BY PROCEDURE, 2015 & 2020 ($MILLION) 40
4.5 MEDICAL AESTHETICS MARKET, BY END USER, 2012–2020 ($MILLION) 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.2.1 MEDICAL AESTHETICS MARKET, BY PRODUCT 43
5.2.2 MEDICAL AESTHETICS MARKET, BY PROCEDURE 44
5.2.3 MEDICAL AESTHETICS MARKET, BY END USER 44
5.3 MARKET DYNAMICS 45
5.3.1 DRIVERS 46
5.3.1.1 Growing adoption of minimally invasive and noninvasive aesthetic procedures 46
5.3.1.2 Aging Population 46
5.3.1.3 Increasing awareness among customers 47
5.3.1.4 Technological advancements in energy-based devices 48
5.3.1.5 Rise in the number of aesthetics procedures 48
5.3.1.6 Increasing demand for aesthetic treatments among the male population 49
5.3.1.7 Improving patient compliance and reliability 49
5.3.2 RESTRAINTS 51
5.3.2.1 Stringent safety regulations for aesthetic procedures 51
5.3.2.2 Social Stigmas attached to cosmetic treatments 52
5.3.2.3 Product recalls 52
5.3.2.4 Low focus of market players on development of medical aesthetic devices for dermatological conditions 53
5.3.3 OPPORTUNITIES 54
5.3.3.1 Emerging markets offer lucrative growth opportunities 54
5.3.3.2 Development of low-cost medical aesthetic devices 55
5.3.3.3 Growing adoption of home-use aesthetic devices 55
5.3.4 CHALLENGES 56
5.3.4.1 Sustainability of players in the highly competitive market 56
5.3.4.2 Rising adoption of branded beauty and cosmetic products 57
5.3.5 INDUSTRY TRENDS 58
5.3.5.1 Growing importance of social media in the medical aesthetic industry 58
5.3.5.2 Industry consolidations 58
5.3.5.3 Shift from reconstructive aesthetic surgery to cosmetic treatment in the U.S. 59
5.3.6 BURNING ISSUES 60
5.3.6.1 Regulatory hurdles 60
5.3.6.2 Reimbursement issues 61
5.3.6.2.1 Lack of reimbursement for cosmetic procedures 61
5.3.6.2.2 Decreasing reimbursements for reconstructive aesthetic procedures 61
?
5.3.7 NEW ADVANCEMENTS IN AESTHETICS 62
5.3.7.1 Skin tightening 62
5.3.7.2 Noninvasive fat reduction 63
5.3.7.3 Fractional lasers and radiofrequency technology 63
5.3.7.4 Tattoo removal technology 63
6 MEDICAL AESTHETICS MARKET, BY PRODUCT 65
6.1 INTRODUCTION 66
6.2 AESTHETIC LASERS AND ENERGY DEVICES 66
6.2.1 LASER RESURFACING DEVICES 68
6.2.1.1 Ablative Skin Resurfacing Devices 69
6.2.1.2 Nonablative Skin Resurfacing Devices 70
6.2.2 BODY CONTOURING DEVICES 71
6.2.2.1 Liposuction Devices 72
6.2.2.1.1 Laser-assisted Liposuction Devices 73
6.2.2.1.2 Ultrasound-assisted Liposuction Devices 73
6.2.2.1.3 Radiofrequency-assisted Liposuction Devices 74
6.2.2.1.4 Water Jet-assisted Liposuction Devices 75
6.2.2.1.5 Other Liposuction Devices 75
6.2.2.2 Cellulite Reduction Devices 76
6.2.2.2.1 Energy-based Cellulite Reduction Devices 77
6.2.2.2.2 Lipomassage Devices 78
6.2.2.2.3 Mesotherapy Devices 78
6.2.2.3 Nonsurgical Fat Reduction Devices 79
6.2.2.3.1 Cryolipolysis Devices 80
6.2.2.3.2 Laser-based Devices 80
6.2.2.3.3 Radiofrequency-based Devices 81
6.2.2.3.4 Ultrasound-based Devices 82
6.2.2.4 Nonsurgical Skin Tightening Devices 82
6.2.2.4.1 Laser-based Skin Tightening Devices 84
6.2.2.4.2 Radiofrequency-based Skin Tightening Devices 84
6.2.2.4.3 Ultrasound-based Skin Tightening Devices 85
6.2.2.4.4 Other skin tightening devices 86
6.2.3 AESTHETIC OPHTHALMOLOGY & OCULOPLASTIC DEVICES 86
6.2.4 LASER HAIR REMOVAL DEVICES 87
6.3 AESTHETIC IMPLANTS 88
6.3.1 BREAST IMPLANTS 89
6.3.1.1 Silicone Breast Implants 90
6.3.1.2 Saline Breast Implants 91
6.3.1.3 Cohesive Semi-Solid Gel Breast Implants 92
?
6.3.2 OTHER IMPLANTS 93
6.3.2.1 Aesthetic Dental Implants 94
6.3.2.2 Soft-tissue Implants 94
6.4 FACIAL AESTHETICS DEVICES 95
6.4.1 BOTULINUM TOXIN 96
6.4.2 DERMAL FILLERS 97
6.4.2.1 Absorbable Dermal Fillers/Temporary Dermal Fillers 98
6.4.2.2 Nonabsorbable Dermal Fillers/Permanent Dermal Fillers 99
6.4.3 CHEMICAL PEEL 99
6.4.4 MICRODERMABRASION 100
7 MEDICAL AESTHETICS MARKET, BY END USER 101
7.1 INTRODUCTION 102
7.2 CLINICS/BEAUTY CENTERS 103
7.2.1 COSMETIC PROCEDURES 104
7.2.2 RECONSTRUCTIVE PROCEDURES 105
7.3 HOME SETTINGS 106
8 MEDICAL AESTHETICS MARKET, BY PROCEDURE 108
8.1 INTRODUCTION 109
8.2 COSMETIC PROCEDURES 110
8.2.1 MINIMALLY INVASIVE PROCEDURES 111
8.2.2 SURGICAL PROCEDURES 112
8.3 RECONSTRUCTIVE PROCEDURES 113
9 GLOBAL MEDICAL AESTHETICS MARKET, BY REGION 114
9.1 INTRODUCTION 115
9.2 NORTH AMERICA 117
9.2.1 GROWING PROCEDURAL VOLUME FOR AESTHETIC PROCEDURES 118
9.2.2 FDA APPROVAL FOR HOME-USE AESTHETICS DEVICES 118
9.2.3 RAPIDLY INCREASING AGING AND OBESE POPULATION 118
9.2.4 LAUNCH OF INNOVATIVE AESTHETIC PRODUCTS 119
9.2.5 RICH RESEARCH PIPELINE 119
9.2.6 ENTRY OF SUBSTANDARD AND UNAPPROVED PRODUCTS IN THE SUPPLY CHAIN HINDERING MARKET GROWTH 120
9.2.7 LACK OF REIMBURSEMENT AND HIGH COST OF AESTHETIC PROCEDURES 120
9.3 EUROPE 126
9.3.1 INCREASE IN THE NUMBER OF AESTHETIC PROCEDURES PERFORMED 127
9.3.2 LAUNCH OF NOVEL RF AND LASER-BASED AESTHETIC PRODUCTS 127
9.3.3 BREAST AUGMENTATION AND LIPOSUCTION ARE THE MOST-PRACTICED SURGICAL INTERVENTIONS IN EUROPE 127
9.3.4 HIGH USE OF DERMAL FILLERS IN EUROPE 128
9.3.5 ORGANIZATION OF CONFERENCES AND TRAINING PROGRAMS 128
9.3.6 GROWING INVESTMENTS BY MARKET PLAYERS TO DEVELOP AESTHETIC PRODUCTS 129
9.3.7 DEARTH OF PROPER REGULATORY GUIDELINES 129
9.3.8 SLOW MARKET GROWTH DUE TO ECONOMIC CRISIS AND REIMBURSEMENT ISSUES 129
9.4 ASIA-PACIFIC 136
9.4.1 RISING MIDDLE CLASS AND PURCHASING POWER IN THE REGION 137
9.4.2 GROWING INCLINATION TOWARDS NONINVASIVE, MINIMALLY INVASIVE SURGERIES 137
9.4.3 GROWING OBSESSION FOR AESTHETIC SURGERY IN SOUTH KOREA DUE TO DECREASING TABOOS AND RISING MEDICAL TOURISM 137
9.4.4 INCREASING FOCUS OF GLOBAL PLAYERS ON THE ASIA-PACIFIC AESTHETICS MARKET 138
9.4.5 LAUNCH OF NOVEL AESTHETIC DEVICES 138
9.4.6 GROWING USES OF NEUROTOXINS 139
9.4.7 LOWER NUMBER OF OBESE PATIENTS, AS COMPARED TO NORTH AMERICA AND EUROPE 139
9.4.8 SLOW GROWTH OF DERMAL FILLERS MARKET COMPARED TO NEUROTOXINS 140
9.4.9 LACK OF REIMBURSEMENT 140
9.5 REST OF THE WORLD 146
9.5.1 RISE IN MEDICAL TOURISM 146
9.5.2 RISING NUMBER OF AESTHETIC PROCEDURES ACROSS THE REGION 146
9.5.3 INCREASING NUMBER OF SURGICAL PROCEDURES IN BRAZIL 147
9.5.4 GROWING FOCUS OF GLOBAL PLAYERS ON THE LATIN AMERICAN REGION 147
9.5.5 INCREASING AWARENESS WITH REGARD TO AESTHETIC PROCEDURES 148
9.5.6 PRESENCE OF LEADING AESTHETIC DEVICES MANUFACTURER IN ISRAEL 148
9.5.7 WEAK ECONOMY AND LOW CONSUMER BUYING POWER 148
9.5.8 SHORTAGE OF PLASTIC SURGEONS IN THE MIDDLE EAST AND AFRICA 148
10 COMPETITIVE LANDSCAPE 155
10.1 INTRODUCTION 155
10.2 MARKET SHARE ANALYSIS, BY KEY PLAYER 157
10.2.1 MEDICAL AESTHETIC LASERS AND ENERGY DEVICES MARKET 157
10.2.2 FACIAL AESTHETICS MARKET 157
10.2.2.1 Botulinum Toxins Market 158
10.2.2.2 Dermal Fillers Market 158
10.2.3 BREAST IMPLANTS MARKET 159
10.3 COMPETITIVE SITUATION AND TRENDS 160
10.3.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 160
10.3.2 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS 161
10.3.3 MERGERS AND ACQUISITIONS 162
10.3.4 GEOGRAPHICAL EXPANSION 163
10.3.5 OTHER DEVELOPMENTS 163
11 COMPANY PROFILES 165
11.1 INTRODUCTION 165
11.2 ALLERGAN, INC. (A DIVISION OF ACTAVIS PLC) 166
11.2.1 BUSINESS OVERVIEW 166
11.2.2 PRODUCT PORTFOLIO 167
11.2.3 RECENT DEVELOPMENTS 167
11.2.4 MNM VIEW 168
11.3 SOLTA MEDICAL, INC. (A DIVISION OF VALEANT PHARMACEUTICALS INTERNATIONAL, INC.) 169
11.3.1 BUSINESS OVERVIEW 169
11.3.2 PRODUCT PORTFOLIO 170
11.3.3 RECENT DEVELOPMENTS 170
11.4 SYNERON MEDICAL LTD. 172
11.4.1 BUSINESS OVERVIEW 172
11.4.2 PRODUCT PORTFOLIO 173
11.4.3 RECENT DEVELOPMENTS 173
11.4.4 MNM VIEW 175
11.5 PHOTOMEDEX, INC. 176
11.5.1 BUSINESS OVERVIEW 176
11.5.2 PRODUCTS AND SERVICES 177
11.5.3 RECENT DEVELOPMENTS 177
11.6 CYNOSURE, INC. 178
11.6.1 BUSINESS OVERVIEW 178
11.6.2 PRODUCT PORTFOLIO 179
11.6.3 RECENT DEVELOPMENTS 180
11.6.4 MNM VIEW 181
11.7 LUMENIS LTD. 182
11.7.1 BUSINESS OVERVIEW 182
11.7.2 PRODUCT PORTFOLIO 183
11.7.3 RECENT DEVELOPMENTS 183
11.8 JOHNSON AND JOHNSON 185
11.8.1 BUSINESS OVERVIEW 185
11.8.2 PRODUCT PORTFOLIO 186
11.8.3 RECENT DEVELOPMENTS 187
11.9 ZELTIQ AESTHETICS, INC. 188
11.9.1 BUSINESS OVERVIEW 188
11.9.2 PRODUCT PORTFOLIO 189
11.9.3 RECENT DEVELOPMENTS 189
11.10 MERZ AESTHETICS, INC. (A DIVISION OF MERZ PHARMA GMBH & CO. KGAA) 191
11.10.1 BUSINESS OVERVIEW 191
11.10.2 PRODUCT PORTFOLIO 192
11.10.3 RECENT DEVELOPMENTS 193
11.11 GALDERMA S.A. (A SUBSIDIARY OF NESTLE S.A.) 194
11.11.1 BUSINESS OVERVIEW 194
11.11.2 PRODUCT PORTFOLIO 195
11.11.3 RECENT DEVELOPMENTS 195
11.11.4 MNM VIEW 196
11.12 ALMA LASERS, LTD. (ACQUIRED BY SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.) 197
11.12.1 BUSINESS OVERVIEW 197
11.12.2 PRODUCT PORTFOLIO: 198
11.12.3 RECENT DEVELOPMENTS 198
12 APPENDIX 200
12.1 INSIGHTS OF INDUSTRY EXPERTS 200
12.2 DISCUSSION GUIDE 201
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 205
12.4 AVAILABLE CUSTOMIZATIONS 207
12.5 RELATED REPORTS 208